Jordi Heijman

Atrial cardiomyopathy: from knowledge gaps to clinical impact

Abstract Background Atrial cardiomyopathy (AtCM) is increasingly recognised as an underlying atrial substrate contributing to atrial fibrillation (AF), heart failure (HF), and cardio-embolic stroke. However, diagnostic criteria, disease thresholds, and targeted treatment strategi...